{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T05:50:19Z","timestamp":1791697819673,"version":"4.3.4"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T00:00:00Z","timestamp":1757894400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T00:00:00Z","timestamp":1757894400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bioprocess Biosyst Eng"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s00449-025-03232-3","type":"journal-article","created":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T04:43:19Z","timestamp":1757911399000},"page":"2125-2136","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Prevalence and effective treatment of drug-resistant Pseudomonas aeruginosa biofilm using flavonoid naringin"],"prefix":"10.1007","volume":"48","author":[{"given":"Subramanian","family":"Palaniappan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinothini","family":"Gunasekaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thavasumani","family":"Muthu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lekha Sree","family":"Venkatesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Palanivel","family":"Sathishkumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,15]]},"reference":[{"key":"3232_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2023.106453","volume":"185","author":"N Rohatgi","year":"2023","unstructured":"Rohatgi N, Ganapathy D, Sathishkumar P (2023) Eradication of Pseudomonas aeruginosa biofilm using quercetin-mediated copper oxide nanoparticles incorporated in the electrospun polycaprolactone nanofibrous scaffold. Microb Pathog 185:106453. https:\/\/doi.org\/10.1016\/j.micpath.2023.106453","journal-title":"Microb Pathog"},{"key":"3232_CR2","unstructured":"Pseudomonas aeruginosa Infection. . In: Cleveland Clinic"},{"key":"3232_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2024.107103","author":"P Sathishkumar","year":"2024","unstructured":"Sathishkumar P, Khan F (2024) Leveraging bacteria-inspired nanomaterials for targeted controlling biofilm and virulence properties of Pseudomonas aeruginosa. Microb Pathog. https:\/\/doi.org\/10.1016\/j.micpath.2024.107103","journal-title":"Microb Pathog"},{"key":"3232_CR4","doi-asserted-by":"publisher","first-page":"116674","DOI":"10.1016\/j.diagmicrobio.2024.116674","volume":"111","author":"G S","year":"2025","unstructured":"S G, Pathoor NN, Murthykumar K, Ganesh PS (2025) Targeting Pseudomonas aeruginosa PAO1 pathogenicity: the role of Glycyrrhiza glabra in inhibiting virulence factors and biofilms. Diagn Microbiol Infect Dis 111:116674. https:\/\/doi.org\/10.1016\/j.diagmicrobio.2024.116674","journal-title":"Diagn Microbiol Infect Dis"},{"key":"3232_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioflm.2021.100056","volume":"3","author":"D Sindeldecker","year":"2021","unstructured":"Sindeldecker D, Stoodley P (2021) The many antibiotic resistance and tolerance strategies of Pseudomonas aeruginosa. Biofilm 3:100056. https:\/\/doi.org\/10.1016\/j.bioflm.2021.100056","journal-title":"Biofilm"},{"key":"3232_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.micres.2024.127656","volume":"282","author":"BA Omran","year":"2024","unstructured":"Omran BA, Tseng BS, Baek K-H (2024) Nanocomposites against Pseudomonas aeruginosa biofilms: recent advances, challenges, and future prospects. Microbiol Res 282:127656. https:\/\/doi.org\/10.1016\/j.micres.2024.127656","journal-title":"Microbiol Res"},{"key":"3232_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2024.116674","volume":"111","author":"S G","year":"2025","unstructured":"G S, Pathoor NN, Murthykumar K, Ganesh PS (2025) Targeting Pseudomonas aeruginosa PAO1 pathogenicity: the role of Glycyrrhiza glabra in inhibiting virulence factors and biofilms. Diagn Microbiol Infect Dis 111:116674. https:\/\/doi.org\/10.1016\/j.diagmicrobio.2024.116674","journal-title":"Diagn Microbiol Infect Dis"},{"key":"3232_CR8","doi-asserted-by":"publisher","DOI":"10.1080\/14786419.2024.2429522","author":"TM Martin","year":"2024","unstructured":"Martin TM, Guru A (2024) Exploring peptaibols from Trichoderma lentiforme as a novel treatment for Carbapenem-resistant Pseudomonas aeruginosa infections. Nat Prod Res. https:\/\/doi.org\/10.1080\/14786419.2024.2429522","journal-title":"Nat Prod Res"},{"key":"3232_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2024.107105","volume":"198","author":"K Vadakkan","year":"2025","unstructured":"Vadakkan K, Jose B, Mapranathukaran VO et al (2025) Biofilm suppression of Pseudomonas aeruginosa by bio-engineered silver nanoparticles from Hellenia speciosa rhizome extract. Microb Pathog 198:107105. https:\/\/doi.org\/10.1016\/j.micpath.2024.107105","journal-title":"Microb Pathog"},{"key":"3232_CR10","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.biotechadv.2018.11.013","volume":"37","author":"Z Pang","year":"2019","unstructured":"Pang Z, Raudonis R, Glick BR et al (2019) Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies. Biotechnol Adv 37:177\u2013192. https:\/\/doi.org\/10.1016\/j.biotechadv.2018.11.013","journal-title":"Biotechnol Adv"},{"key":"3232_CR11","doi-asserted-by":"publisher","DOI":"10.1111\/1751-7915.14487","author":"W Wu","year":"2024","unstructured":"Wu W, Huang J, Xu Z (2024) Antibiotic influx and efflux in Pseudomonas aeruginosa: regulation and therapeutic implications. Microb Biotechnol. https:\/\/doi.org\/10.1111\/1751-7915.14487","journal-title":"Microb Biotechnol"},{"key":"3232_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2024.106998","volume":"196","author":"C Thamayandhi","year":"2024","unstructured":"Thamayandhi C, El-Tayeb MA, Syed SRM et al (2024) Antibacterial and anti-biofilm efficacy of selenium nanoparticles against Pseudomonas aeruginosa: characterization and in vitro analysis. Microb Pathog 196:106998. https:\/\/doi.org\/10.1016\/j.micpath.2024.106998","journal-title":"Microb Pathog"},{"key":"3232_CR13","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/s41392-022-01056-1","volume":"7","author":"S Qin","year":"2022","unstructured":"Qin S, Xiao W, Zhou C et al (2022) Pseudomonas aeruginosa: pathogenesis, virulence factors, antibiotic resistance, interaction with host, technology advances and emerging therapeutics. Signal Transduct Target Ther 7:199. https:\/\/doi.org\/10.1038\/s41392-022-01056-1","journal-title":"Signal Transduct Target Ther"},{"key":"3232_CR14","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1038\/s42003-022-04230-x","volume":"5","author":"LF Avila-Cobian","year":"2022","unstructured":"Avila-Cobian LF, De Benedetti S, Kim C et al (2022) In vitro studies of the protein-interaction network of cell-wall lytic transglycosylase RlpA of Pseudomonas aeruginosa. Commun Biol 5:1314. https:\/\/doi.org\/10.1038\/s42003-022-04230-x","journal-title":"Commun Biol"},{"key":"3232_CR15","doi-asserted-by":"publisher","first-page":"13586","DOI":"10.1073\/pnas.0803391105","volume":"105","author":"H Chen","year":"2008","unstructured":"Chen H, Hu J, Chen PR et al (2008) The Pseudomonas aeruginosa multidrug efflux regulator MexR uses an oxidation-sensing mechanism. Proc Natl Acad Sci U S A 105:13586\u201313591. https:\/\/doi.org\/10.1073\/pnas.0803391105","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3232_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.micres.2024.127872","volume":"288","author":"L Dong","year":"2024","unstructured":"Dong L, Sun L, Yang Y et al (2024) Non-antibiotic pharmaceutical phenylbutazone binding to MexR reduces the antibiotic susceptibility of Pseudomonas aeruginosa. Microbiol Res 288:127872. https:\/\/doi.org\/10.1016\/j.micres.2024.127872","journal-title":"Microbiol Res"},{"key":"3232_CR17","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.ijid.2023.11.023","volume":"139","author":"Y Li","year":"2024","unstructured":"Li Y, Roberts JA, Walker MM et al (2024) The global epidemiology of ventilator-associated pneumonia caused by multi-drug resistant Pseudomonas aeruginosa: a systematic review and meta-analysis. Int J Infect Dis 139:78\u201385. https:\/\/doi.org\/10.1016\/j.ijid.2023.11.023","journal-title":"Int J Infect Dis"},{"key":"3232_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2024.107243","author":"G-J Jeong","year":"2024","unstructured":"Jeong G-J, Khan F, Tabassum N et al (2024) Strategies for controlling polymicrobial biofilms: a focus on antibiofilm agents. Int J Antimicrob Agents. https:\/\/doi.org\/10.1016\/j.ijantimicag.2024.107243","journal-title":"Int J Antimicrob Agents"},{"key":"3232_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.hermed.2024.100905","volume":"46","author":"A Sakthivel","year":"2024","unstructured":"Sakthivel A, Sankaran K, Rengasamy G et al (2024) Formulation of mouthwash using combined herbal extracts to control the predominant oral pathogens and biofilm. J Herb Med 46:100905. https:\/\/doi.org\/10.1016\/j.hermed.2024.100905","journal-title":"J Herb Med"},{"key":"3232_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.155535","volume":"128","author":"J Zhang","year":"2024","unstructured":"Zhang J, Mao-mao SM, Wang M (2024) Therapeutic potential of natural flavonoids in pulmonary arterial hypertension: a review. Phytomedicine 128:155535. https:\/\/doi.org\/10.1016\/j.phymed.2024.155535","journal-title":"Phytomedicine"},{"key":"3232_CR21","first-page":"1","volume-title":"Handbook of Dietary Flavonoids","author":"T Ozdal","year":"2023","unstructured":"Ozdal T, Caba ZT, Karaca AC et al (2023) Naringenin: Advances on Resources, Biosynthesis Pathway, Bioavailability, Bioactivity, and Pharmacology. Handbook of Dietary Flavonoids. Springer International Publishing, Cham, pp 1\u201335"},{"key":"3232_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2020.173578","volume":"888","author":"X Ma","year":"2020","unstructured":"Ma X, Jiang Y, Wen J et al (2020) A comprehensive review of natural products to fight liver fibrosis: alkaloids, terpenoids, glycosides, coumarins and other compounds. Eur J Pharmacol 888:173578. https:\/\/doi.org\/10.1016\/j.ejphar.2020.173578","journal-title":"Eur J Pharmacol"},{"key":"3232_CR23","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01934-17","author":"RM Humphries","year":"2018","unstructured":"Humphries RM, Ambler J, Mitchell SL et al (2018) CLSI methods development and standardization working group best practices for evaluation of antimicrobial susceptibility tests. J Clin Microbiol. https:\/\/doi.org\/10.1128\/JCM.01934-17","journal-title":"J Clin Microbiol"},{"key":"3232_CR24","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.tube.2013.12.002","volume":"94","author":"AH Diacon","year":"2014","unstructured":"Diacon AH, van der Merwe L, Demers A-M et al (2014) Time to positivity in liquid culture predicts colony forming unit counts of Mycobacterium tuberculosis in sputum specimens. Tuberculosis 94:148\u2013151. https:\/\/doi.org\/10.1016\/j.tube.2013.12.002","journal-title":"Tuberculosis"},{"key":"3232_CR25","unstructured":"W. L. Delano (2002) The PyMOL Molecular Graphics System"},{"key":"3232_CR26","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.apsusc.2019.07.010","volume":"493","author":"P Sathishkumar","year":"2019","unstructured":"Sathishkumar P, Li Z, Huang B et al (2019) Understanding the surface functionalization of myricetin-mediated gold nanoparticles: experimental and theoretical approaches. Appl Surf Sci 493:634\u2013644. https:\/\/doi.org\/10.1016\/j.apsusc.2019.07.010","journal-title":"Appl Surf Sci"},{"key":"3232_CR27","doi-asserted-by":"publisher","first-page":"e159","DOI":"10.1016\/S2666-5247(22)00329-9","volume":"4","author":"J Reyes","year":"2023","unstructured":"Reyes J, Komarow L, Chen L et al (2023) Global epidemiology and clinical outcomes of carbapenem-resistant Pseudomonas aeruginosa and associated carbapenemases (POP): a prospective cohort study. Lancet Microbe 4:e159\u2013e170. https:\/\/doi.org\/10.1016\/S2666-5247(22)00329-9","journal-title":"Lancet Microbe"},{"key":"3232_CR28","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.3201\/eid\/1706.100358","volume":"17","author":"E Akhabue","year":"2011","unstructured":"Akhabue E, Synnestvedt M, Weiner MG et al (2011) Cefepime-Resistant Pseudomonas aeruginosa. Emerg Infect Dis 17:1037\u20131043. https:\/\/doi.org\/10.3201\/eid\/1706.100358","journal-title":"Emerg Infect Dis"},{"key":"3232_CR29","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12866-021-02427-4","volume":"22","author":"S Nasrin","year":"2022","unstructured":"Nasrin S, Hegerle N, Sen S et al (2022) Distribution of serotypes and antibiotic resistance of invasive Pseudomonas aeruginosa in a multi-country collection. BMC Microbiol 22:13. https:\/\/doi.org\/10.1186\/s12866-021-02427-4","journal-title":"BMC Microbiol"},{"key":"3232_CR30","doi-asserted-by":"publisher","first-page":"4113","DOI":"10.2147\/IDR.S409726","volume":"16","author":"AM Momenah","year":"2023","unstructured":"Momenah AM, Bakri RA, Jalal NA et al (2023) Antimicrobial resistance pattern of Pseudomonas aeruginosa: an 11-year experience in a tertiary care hospital in Makkah, Saudi Arabia. Infect Drug Resist 16:4113\u20134122. https:\/\/doi.org\/10.2147\/IDR.S409726","journal-title":"Infect Drug Resist"},{"key":"3232_CR31","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.jcf.2009.08.004","volume":"8","author":"F Ratjen","year":"2009","unstructured":"Ratjen F, Brockhaus F, Angyalosi G (2009) Aminoglycoside therapy against Pseudomonas aeruginosa in cystic fibrosis: a review. J Cyst Fibros 8:361\u2013369. https:\/\/doi.org\/10.1016\/j.jcf.2009.08.004","journal-title":"J Cyst Fibros"},{"key":"3232_CR32","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1002\/pro.3815","volume":"29","author":"C Semper","year":"2020","unstructured":"Semper C, Stogios P, Meziane-Cherif D et al (2020) Structural characterization of aminoglycoside 4\u2032- O -adenylyltransferase ANT(4\u2032)-IIb from Pseudomonas aeruginosa. Protein Sci 29:758\u2013767. https:\/\/doi.org\/10.1002\/pro.3815","journal-title":"Protein Sci"},{"key":"3232_CR33","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1128\/AAC.45.2.480-484.2001","volume":"45","author":"H Pai","year":"2001","unstructured":"Pai H, Kim J-W, Kim J et al (2001) Carbapenem resistance mechanisms in Pseudomonas aeruginosa clinical isolates. Antimicrob Agents Chemother 45:480\u2013484. https:\/\/doi.org\/10.1128\/AAC.45.2.480-484.2001","journal-title":"Antimicrob Agents Chemother"},{"key":"3232_CR34","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1007\/s10096-018-3244-4","volume":"37","author":"T Karampatakis","year":"2018","unstructured":"Karampatakis T, Antachopoulos C, Tsakris A, Roilides E (2018) Molecular epidemiology of carbapenem-resistant Pseudomonas aeruginosa in an endemic area: comparison with global data. Eur J Clin Microbiol Infect Dis 37:1211\u20131220. https:\/\/doi.org\/10.1007\/s10096-018-3244-4","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"3232_CR35","unstructured":"Tannic Acid (2024) What are the side effects of Tannic Acid? Synapse"},{"key":"3232_CR36","doi-asserted-by":"publisher","first-page":"405","DOI":"10.3390\/biomedicines8100405","volume":"8","author":"FJ \u00c1lvarez-Mart\u00ednez","year":"2020","unstructured":"\u00c1lvarez-Mart\u00ednez FJ, Barraj\u00f3n-Catal\u00e1n E, Micol V (2020) Tackling antibiotic resistance with compounds of natural origin: a comprehensive review. Biomedicines 8:405. https:\/\/doi.org\/10.3390\/biomedicines8100405","journal-title":"Biomedicines"},{"key":"3232_CR37","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.3390\/molecules27041149","volume":"27","author":"NF Shamsudin","year":"2022","unstructured":"Shamsudin NF, Ahmed QU, Mahmood S et al (2022) Antibacterial effects of flavonoids and their structure-activity relationship study: a comparative interpretation. Molecules 27:1149. https:\/\/doi.org\/10.3390\/molecules27041149","journal-title":"Molecules"},{"key":"3232_CR38","doi-asserted-by":"publisher","first-page":"4064","DOI":"10.1074\/jbc.M116.770552","volume":"292","author":"JE Paczkowski","year":"2017","unstructured":"Paczkowski JE, Mukherjee S, McCready AR et al (2017) Flavonoids suppress Pseudomonas aeruginosa virulence through allosteric inhibition of quorum-sensing receptors. J Biol Chem 292:4064\u20134076. https:\/\/doi.org\/10.1074\/jbc.M116.770552","journal-title":"J Biol Chem"},{"key":"3232_CR39","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1186\/s40064-015-1645-8","volume":"4","author":"AT Mbaveng","year":"2015","unstructured":"Mbaveng AT, Sandjo LP, Tankeo SB et al (2015) Antibacterial activity of nineteen selected natural products against multi-drug resistant Gram-negative phenotypes. Springerplus 4:823. https:\/\/doi.org\/10.1186\/s40064-015-1645-8","journal-title":"Springerplus"},{"key":"3232_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2024\/6213873","volume":"2024","author":"M Motevasel","year":"2024","unstructured":"Motevasel M, Haghkhah M, Azimzadeh N (2024) Phylogenetic aspects of antibiotic resistance and biofilm formation of P. aeruginosa isolated from clinical samples. Can J Infect Dis Med Microbiol 2024:1\u20139. https:\/\/doi.org\/10.1155\/2024\/6213873","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"3232_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.135130","volume":"279","author":"A Kar","year":"2024","unstructured":"Kar A, Saha P, De R et al (2024) Unveiling the role of PA0730.1 sRNA in Pseudomonas aeruginosa virulence and biofilm formation: exploring rpoS and mucA regulation. Int J Biol Macromol 279:135130. https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.135130","journal-title":"Int J Biol Macromol"},{"key":"3232_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2025.107652","volume":"205","author":"S Sherafati","year":"2025","unstructured":"Sherafati S, Gholami M, Ebrahimzadeh MA, Goli HR (2025) Inhibitory effect of naringin, naringenin, and crocin on biofilm formation and lecA gene expression in Pseudomonas aeruginosa clinical isolates. Microb Pathog 205:107652. https:\/\/doi.org\/10.1016\/j.micpath.2025.107652","journal-title":"Microb Pathog"},{"key":"3232_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.mgene.2020.100646","volume":"23","author":"WM Abdelraheem","year":"2020","unstructured":"Abdelraheem WM, Abdelkader AE, Mohamed ES, Mohammed MS (2020) Detection of biofilm formation and assessment of biofilm genes expression in different Pseudomonas aeruginosa clinical isolates. Meta Gene 23:100646. https:\/\/doi.org\/10.1016\/j.mgene.2020.100646","journal-title":"Meta Gene"},{"key":"3232_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.genrep.2021.101157","volume":"23","author":"E Haghighifar","year":"2021","unstructured":"Haghighifar E, Dolatabadi RK, Norouzi F (2021) Prevalence of blaVEB and blaTEM genes, antimicrobial resistance pattern and biofilm formation in clinical isolates of Pseudomonas aeruginosa from burn patients in Isfahan, Iran. Gene Rep 23:101157. https:\/\/doi.org\/10.1016\/j.genrep.2021.101157","journal-title":"Gene Rep"},{"key":"3232_CR45","doi-asserted-by":"publisher","first-page":"5024","DOI":"10.3390\/molecules25215024","volume":"25","author":"F Guzzo","year":"2020","unstructured":"Guzzo F, Scognamiglio M, Fiorentino A et al (2020) Plant derived natural products against Pseudomonas aeruginosa and Staphylococcus aureus: antibiofilm activity and molecular mechanisms. Molecules 25:5024. https:\/\/doi.org\/10.3390\/molecules25215024","journal-title":"Molecules"},{"key":"3232_CR46","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.micpath.2019.04.005","volume":"131","author":"S Hnamte","year":"2019","unstructured":"Hnamte S, Parasuraman P, Ranganathan S et al (2019) Mosloflavone attenuates the quorum sensing controlled virulence phenotypes and biofilm formation in Pseudomonas aeruginosa PAO1: in vitro, in vivo and in silico approach. Microb Pathog 131:128\u2013134. https:\/\/doi.org\/10.1016\/j.micpath.2019.04.005","journal-title":"Microb Pathog"},{"key":"3232_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijmm.2020.151410","volume":"310","author":"P Dey","year":"2020","unstructured":"Dey P, Parai D, Banerjee M et al (2020) Naringin sensitizes the antibiofilm effect of ciprofloxacin and tetracycline against Pseudomonas aeruginosa biofilm. Int J Med Microbiol 310:151410. https:\/\/doi.org\/10.1016\/j.ijmm.2020.151410","journal-title":"Int J Med Microbiol"},{"key":"3232_CR48","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.sjbs.2020.10.009","volume":"28","author":"FM Husain","year":"2021","unstructured":"Husain FM, Perveen K, Qais FA et al (2021) Naringin inhibits the biofilms of metallo-\u03b2-lactamases (M\u03b2Ls) producing Pseudomonas species isolated from camel meat. Saudi J Biol Sci 28:333\u2013341. https:\/\/doi.org\/10.1016\/j.sjbs.2020.10.009","journal-title":"Saudi J Biol Sci"},{"key":"3232_CR49","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1042\/EBC20160065","volume":"61","author":"VK Ramaswamy","year":"2017","unstructured":"Ramaswamy VK, Cacciotto P, Malloci G et al (2017) Computational modelling of efflux pumps and their inhibitors. Essays Biochem 61:141\u2013156. https:\/\/doi.org\/10.1042\/EBC20160065","journal-title":"Essays Biochem"},{"key":"3232_CR50","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.jpha.2019.11.002","volume":"10","author":"AJ Seukep","year":"2020","unstructured":"Seukep AJ, Kuete V, Nahar L et al (2020) Plant-derived secondary metabolites as the main source of efflux pump inhibitors and methods for identification. J Pharm Anal 10:277\u2013290. https:\/\/doi.org\/10.1016\/j.jpha.2019.11.002","journal-title":"J Pharm Anal"},{"key":"3232_CR51","doi-asserted-by":"publisher","first-page":"7363","DOI":"10.1128\/jb.175.22.7363-7372.1993","volume":"175","author":"K Poole","year":"1993","unstructured":"Poole K, Krebes K, McNally C, Neshat S (1993) Multiple antibiotic resistance in Pseudomonas aeruginosa: evidence for involvement of an efflux operon. J Bacteriol 175:7363\u20137372. https:\/\/doi.org\/10.1128\/jb.175.22.7363-7372.1993","journal-title":"J Bacteriol"},{"key":"3232_CR52","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1128\/AAC.40.9.2021","volume":"40","author":"K Poole","year":"1996","unstructured":"Poole K, Tetro K, Zhao Q et al (1996) Expression of the multidrug resistance operon mexA-mexB-oprM in Pseudomonas aeruginosa: mexR encodes a regulator of operon expression. Antimicrob Agents Chemother 40:2021\u20132028. https:\/\/doi.org\/10.1128\/AAC.40.9.2021","journal-title":"Antimicrob Agents Chemother"},{"key":"3232_CR53","doi-asserted-by":"crossref","unstructured":"Mehtani D, Seth A, Sharma P, et al (2019) Biomaterials for Sustained and Controlled Delivery of Small Drug Molecules. In: Biomaterials and Bionanotechnology. Elsevier, pp 89\u2013152","DOI":"10.1016\/B978-0-12-814427-5.00004-4"},{"key":"3232_CR54","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2018.00099","author":"M Weber","year":"2018","unstructured":"Weber M, Steinle H, Golombek S et al (2018) Blood-contacting biomaterials. In vitro evaluation of the hemocompatibility. Front Bioeng Biotechnol. https:\/\/doi.org\/10.3389\/fbioe.2018.00099","journal-title":"Front Bioeng Biotechnol"},{"key":"3232_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2024.105688","volume":"96","author":"SA Mohamed","year":"2024","unstructured":"Mohamed SA, Helmy MW, Mahmoud HE et al (2024) Cinnamaldehyde \/naringin co-loaded into lactoferrin\/ casienate-coated zein nanoparticles as a gastric resistance oral carrier for mitigating doxorubicin-induced hepatotoxicity. J Drug Deliv Sci Technol 96:105688. https:\/\/doi.org\/10.1016\/j.jddst.2024.105688","journal-title":"J Drug Deliv Sci Technol"},{"key":"3232_CR56","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.aiepr.2023.07.002","volume":"7","author":"M Ul-Islam","year":"2024","unstructured":"Ul-Islam M, Alabbosh KF, Manan S et al (2024) Chitosan-based nanostructured biomaterials: synthesis, properties, and biomedical applications. Adv Ind Eng Polym Res 7:79\u201399. https:\/\/doi.org\/10.1016\/j.aiepr.2023.07.002","journal-title":"Adv Ind Eng Polym Res"}],"container-title":["Bioprocess and Biosystems Engineering"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00449-025-03232-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00449-025-03232-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00449-025-03232-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:08:08Z","timestamp":1761127688000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00449-025-03232-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,15]]},"references-count":56,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["3232"],"URL":"https:\/\/doi.org\/10.1007\/s00449-025-03232-3","relation":{},"ISSN":["1615-7591","1615-7605"],"issn-type":[{"value":"1615-7591","type":"print"},{"value":"1615-7605","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,15]]},"assertion":[{"value":"13 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}